Home › Thyroid Cancer › Tennessee
Thyroid Cancer clinical trials in Tennessee
8 studies for Thyroid Cancer are looking for participants at sites in Tennessee.
Cities in Tennessee
DESTINY-PANTUMOUR04
- Research Site, Nashville
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Sarah Canon Research Institute (SCRI) Oncology Partners, Nashville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 2 to 25 · All sexes · Updated Jul 24, 2026 · NCT06458036A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Nashville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06239194cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist (BHMCC), Memphis
- Vanderbilt-Ingram Cancer Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 2 to 99 · All sexes · Updated Nov 14, 2025 · NCT05783323Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 28, 2025 · NCT05999630From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.